Blockade of 4-1BB (CD137)/4-1BB ligand interactions increases allograft survival

Transplant International : Official Journal of the European Society for Organ Transplantation
H R ChoB S Kwon

Abstract

We investigated the role of 4-1BB, a T cell co-stimulatory molecule, in alloimmune responses. In vivo mixed lymphocyte reactions showed that 4-1BB was preferentially expressed on actively dividing CD4(+) and CD8(+) T cells. Furthermore, following alloantigen challenge, the draining lymph nodes contained subpopulations of 4-1BB-expressing CD4(+) and CD8(+) T cells. 4-1BB-deficient C57BL/6 mice showed a delayed rejection of cardiac transplants mismatched for the major histocompatibility complex. Longer transplant survival was induced by blockade of 4-1BB/4-1BB ligand (4-1BBL) interactions using an anti-4-1BBL monoclonal antibody. Histological analysis showed that prolonged transplant survival in the 4-1BB-deficient and anti-4-1BBL-treated mice correlated with reduced lymphocytic infiltration and vasculitis in the donor heart tissue. Taken together, our data suggest that blockade of 4-1BB/4-1BBL interactions inhibited the expansion of alloreactive T cells and reduced CTL activity against host alloantigen, which in turn resulted in the prolongation of allograft survival. Blockade of the 4-1BB co-stimulatory pathway may be useful for preventing allograft rejection.

Citations

Sep 12, 2013·The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation·Greg HodgeMark Holmes
Nov 7, 2012·Transplantation·Gillian KinnearKathryn J Wood
Jan 12, 2012·Journal of Biomedicine & Biotechnology·Ricardo F AntunesIngrid E Dumitriu
May 8, 2008·Croatian Medical Journal·Qun WangLining Zhang
Sep 12, 2009·Experimental & Molecular Medicine·Young-Mi KimSik Yoon
Feb 24, 2009·Journal of Molecular and Cellular Cardiology·Takaaki HagaToshimitsu Uede
Sep 11, 2007·The Journal of Hand Surgery·Aurèle TaiebW P Andrew Lee
Jun 25, 2015·Frontiers in Oncology·Todd Bartkowiak, Michael A Curran
May 28, 2011·Seminars in Immunology·Nina PilatThomas Wekerle
Oct 7, 2015·Frontiers in Immunology·Kailin LinGang Chen

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allogenic & Autologous Therapies

Allogenic therapies are generated in large batches from unrelated donor tissues such as bone marrow. In contrast, autologous therapies are manufactures as a single lot from the patient being treated. Here is the latest research on allogenic and autologous therapies.

Related Papers

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
Jun WangKenneth A Newell
Seminars in Immunology
Dass S Vinay, B S Kwon
© 2021 Meta ULC. All rights reserved